- Trials with a EudraCT protocol (137)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
137 result(s) found for: Whole Body Imaging.
Displaying page 1 of 7.
EudraCT Number: 2021-003825-31 | Sponsor Protocol Number: GDX-44-015 | Start Date*: 2022-02-28 | ||||||||||||||||
Sponsor Name:Guerbet | ||||||||||||||||||
Full Title: Gadopiclenol Pharmacokinetics, Safety and Efficacy in Pediatric Patients < 2 Years of Age Undergoing Contrast-enhanced MRI P/0145/2019 | ||||||||||||||||||
Medical condition: Known or highly suspected abnormalities/ lesion(s) as detected by previous imaging examinations (including the fetal imaging) that need to be investigated by contrast-enhanced MRI of any body regio... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Ongoing) PL (Ongoing) BG (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000940-17 | Sponsor Protocol Number: 64Cu | Start Date*: 2018-05-07 |
Sponsor Name: | ||
Full Title: Phase IIa clinical study of 64 CuCl2: efficacy and safety of a new tracer for urologic tumors | ||
Medical condition: Genitourinary tract tumors in male patients | ||
Disease: | ||
Population Age: Elderly | Gender: Male | |
Trial protocol: IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-000184-78 | Sponsor Protocol Number: 2020110470 | Start Date*: 2021-06-21 | |||||||||||
Sponsor Name:Odense University Hospital | |||||||||||||
Full Title: Recurrent and Metastatic Prostate Cancer: Impact of 18F-PSMA-1007 PET/CT on clinical decision making and response monitoring | |||||||||||||
Medical condition: Metastatic Prostate Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-003932-26 | Sponsor Protocol Number: Ga-68-CCK2R | Start Date*: 2021-01-20 |
Sponsor Name:Medizinische Universität Innsbruck | ||
Full Title: Phase I/IIa study to evaluate the safety, tolerability, whole-body distribution, and preliminary diagnostic performance of a novel 68Ga-labelled minigastrin analogue in patients with advanced neuro... | ||
Medical condition: Advanced neuroendocrine tumours (NET), including medullary thyroid carcinoma (MTC), as well as gastroenteropancreatic and bronchopulmonary NET | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-000184-24 | Sponsor Protocol Number: EC11-222 | Start Date*: Information not available in EudraCT |
Sponsor Name:ANTONIO JEREZ CALERO | ||
Full Title: Whole body hypothermia + melatonin vs whole body hypothermia + placebo in asphyctic newborns. A multicentric, ramdomized, controlled and double blind clinical trial | ||
Medical condition: Hipothermia plus melatonine neuroprotection terapy in asphixiated newborns. | ||
Disease: | ||
Population Age: Newborns, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-003477-18 | Sponsor Protocol Number: Empabrain01 | Start Date*: 2017-05-04 | |||||||||||
Sponsor Name:University Hospital Tuebingen | |||||||||||||
Full Title: A double-blind randomized study to determine the effect of empagliflozin versus placebo on brain insulin sensitivity in patients with prediabetes | |||||||||||||
Medical condition: brain insulin sensitivity in patients with prediabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002773-21 | Sponsor Protocol Number: 89Zr-TLX250-003 | Start Date*: 2019-04-10 |
Sponsor Name:TELIX International Pty Ltd | ||
Full Title: A confirmatory, prospective, open-label, multi-centre phase 3 study to evaluate diagnostic performance of 89Zirconium-labelled girentuximab(89Zr-TLX250) to non-invasively detect clear cell renal ce... | ||
Medical condition: Patients with an indeterminate renal mass (IRM) detected on contrast-enhanced abdominal MR imaging or equivalent standard of care imaging, clinically suspicious for renal cell carcinoma and schedul... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) GB (GB - no longer in EU/EEA) BE (Completed) ES (Ongoing) | ||
Trial results: View results |
EudraCT Number: 2013-003215-21 | Sponsor Protocol Number: DGD-44-063 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:GUERBET | |||||||||||||
Full Title: DOTAREM® Pharmacokinetics, Safety and Efficacy Study in Pediatric Subjects Aged <2 Years (Term Newborn Infants to Toddlers 23 Months of Age Inclusive) | |||||||||||||
Medical condition: Pediatric subject aged <2 years (term newborn infants to toddlers 23 months of age inclusive) scheduled to undergo routine gadolinium-enhanced Magnetic Resonance Imaging of any body region | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) HU (Completed) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-002751-28 | Sponsor Protocol Number: PVO-2A-201 | Start Date*: 2018-10-16 | |||||||||||
Sponsor Name:Clementia Pharmaceuticals Inc. | |||||||||||||
Full Title: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Palovarotene in Subjects with Multiple Osteochondromas | |||||||||||||
Medical condition: Multiple Osteochondromas (MO) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) GB (Completed) PT (Prematurely Ended) FR (Completed) IT (Prematurely Ended) NL (Completed) BE (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-001811-16 | Sponsor Protocol Number: PS21GAP | Start Date*: 2022-12-19 | |||||||||||
Sponsor Name:Princess Maxima Center for pediatric oncology | |||||||||||||
Full Title: 68Ga-SATO in pediatric neuroblastoma patient; exploratory, safety, non-randomized, open label, comparative study | |||||||||||||
Medical condition: Neuroblastoma | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000952-32 | Sponsor Protocol Number: BAY86-4873/16078 | Start Date*: 2015-09-24 | |||||||||||
Sponsor Name:Bayer HealthCare AG | |||||||||||||
Full Title: Open-label, multi-center study to evaluate the safety, efficacy, and plasma gadolinium concentrations after an intravenous injection of 0.1 mL/kg body weight Eovist/Primovist for enhanced magnetic ... | |||||||||||||
Medical condition: Magnetic Resonance Imaging | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000610-42 | Sponsor Protocol Number: VUmc_2021-5021 | Start Date*: 2021-05-03 |
Sponsor Name:Amsterdam UMC - location VUmc | ||
Full Title: Dynamic and test-retest whole body [18F]FES PET imaging in patients with metastatic ER+ breast cancer. | ||
Medical condition: Metastatic ER+ breast cancer. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-004325-25 | Sponsor Protocol Number: MS325-19 | Start Date*: 2007-01-04 |
Sponsor Name:Administration management, Ludwig-Maximilians-University of Munich | ||
Full Title: Comprehensive whole-body 3T MRA of Patients with Low or Moderate Clinical Probability for Pulmonary Embolism using an Intravascular MR Contrast Agent Vasovist® | ||
Medical condition: Patients with low or moderate clinical probability for pulmonary embolism and positive or negative CTA for pulmonary embolism after CT and sonographic examination for deep venous thrombosis. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-001593-18 | Sponsor Protocol Number: 958 | Start Date*: 2015-06-02 |
Sponsor Name:Medizinische Universiät Wien | ||
Full Title: A pilot study to assess the influence of drug transporters on brain and organ distribution of erlotinib in humans | ||
Medical condition: Investigation in volunteers only | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-004974-27 | Sponsor Protocol Number: BP28015 | Start Date*: 2012-03-26 | |||||||||||
Sponsor Name:University Medical Center Groningen | |||||||||||||
Full Title: 89Zr-RO5323441 PET imaging in patients with recurrent glioblastoma treated with bevacizumab | |||||||||||||
Medical condition: Recurrent malignant glioma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000549-15 | Sponsor Protocol Number: S63678 | Start Date*: 2020-08-05 |
Sponsor Name:University Hospitals Leuven | ||
Full Title: Al18F-NOTA-octreotide PET imaging of the somatostatin receptor in neuroendocrine tumors | ||
Medical condition: Neuroendocrine tumors | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-002784-18 | Sponsor Protocol Number: 13005 | Start Date*: 2018-07-24 | |||||||||||
Sponsor Name:Clinical Trials and Research Governance | |||||||||||||
Full Title: Safety and efficacy of Tofacitinib in ameliorating ischaemia reperfusion injury and allograft pancreatitis in solid organ transplantation – a pilot study | |||||||||||||
Medical condition: Ischaemia reperfusion injury and allograft pancreatitis. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002513-19 | Sponsor Protocol Number: 2011/609-31/1 | Start Date*: 2012-10-29 |
Sponsor Name:Karolinska University Hospital Solna | ||
Full Title: 68Ga-DOTATOC-PET/CT for diagnosis of neuroendocrina tumours | ||
Medical condition: Neuroendocrine tumour | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002045-36 | Sponsor Protocol Number: | Start Date*: 2016-11-17 |
Sponsor Name:University of Oxford, Clinical Trials and Research Governance | ||
Full Title: Lifestyle induced weight loss and Liraglutide in the treatment of non-alcoholic steatohepatitis (NASH) | ||
Medical condition: Non-alcoholic steatohepatitis (NASH) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2018-004530-14 | Sponsor Protocol Number: 1199-0337 | Start Date*: 2019-10-15 | |||||||||||
Sponsor Name:Boehringer Ingelheim España, S.A. | |||||||||||||
Full Title: A double blind, randomised, placebo-controlled trial to evaluate the dose-exposure and safety of nintedanib per os on top of standard of care for 24 weeks, followed by open label treatment with nin... | |||||||||||||
Medical condition: Interstitial Lung Disease | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) PT (Completed) FI (Completed) NO (Completed) DK (Completed) FR (Completed) CZ (Completed) PL (Completed) GR (Completed) HU (Ongoing) GB (GB - no longer in EU/EEA) DE (Completed) BE (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.